132 related articles for article (PubMed ID: 11709427)
1. AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction.
Schuijt MP; Basdew M; van Veghel R; de Vries R; Saxena PR; Schoemaker RG; Danser AH
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2590-6. PubMed ID: 11709427
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation.
Moltzer E; Verkuil AV; van Veghel R; Danser AH; van Esch JH
Hypertension; 2010 Feb; 55(2):516-22. PubMed ID: 20026759
[TBL] [Abstract][Full Text] [Related]
3. No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats.
Schuijt MP; de Vries R; Saxena PR; Danser AH
J Hypertens; 1999 Dec; 17(12 Pt 2):1879-84. PubMed ID: 10703884
[TBL] [Abstract][Full Text] [Related]
4. No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.
Nap A; Balt JC; Pfaffendorf M; Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):100-5. PubMed ID: 12806592
[TBL] [Abstract][Full Text] [Related]
5. Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction.
Merkus D; Haitsma DB; Sorop O; Boomsma F; de Beer VJ; Lamers JM; Verdouw PD; Duncker DJ
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2082-9. PubMed ID: 16798821
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries.
Batenburg WW; Garrelds IM; Bernasconi CC; Juillerat-Jeanneret L; van Kats JP; Saxena PR; Danser AH
Circulation; 2004 May; 109(19):2296-301. PubMed ID: 15117835
[TBL] [Abstract][Full Text] [Related]
7. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
8. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
[TBL] [Abstract][Full Text] [Related]
10. Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
Schuijt MP; de Vries R; Saxena PR; Schalekamp MA; Danser AH
Br J Pharmacol; 2002 Jan; 135(1):275-83. PubMed ID: 11786504
[TBL] [Abstract][Full Text] [Related]
11. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
12. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function.
Zhang C; Hein TW; Wang W; Kuo L
Circ Res; 2003 Feb; 92(3):322-9. PubMed ID: 12595345
[TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine.
Stebbins CL; Symons JD
J Appl Physiol (1985); 1995 Jan; 78(1):185-90. PubMed ID: 7713810
[TBL] [Abstract][Full Text] [Related]
14. Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction.
de Beer VJ; Sorop O; Pijnappels DA; Dekkers DH; Boomsma F; Lamers JM; Duncker DJ; Merkus D
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2069-77. PubMed ID: 18310517
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
[TBL] [Abstract][Full Text] [Related]
16. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
17. Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism.
Verdonk K; Durik M; Abd-Alla N; Batenburg WW; van den Bogaerdt AJ; van Veghel R; Roks AJ; Danser AH; van Esch JH
Hypertension; 2012 Sep; 60(3):722-9. PubMed ID: 22802221
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated.
van Kleef EM; Fingerle J; Daemen MJ
Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):857-63. PubMed ID: 8673560
[TBL] [Abstract][Full Text] [Related]
19. Constrictor and dilator effects of angiotensin II on cerebral arterioles.
Vincent JM; Kwan YW; Chan SL; Perrin-Sarrado C; Atkinson J; Chillon JM
Stroke; 2005 Dec; 36(12):2691-5. PubMed ID: 16269635
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure.
Bautista R; Sánchez A; Hernández J; Oyekan A; Escalante B
Hypertension; 2001 Sep; 38(3 Pt 2):669-73. PubMed ID: 11566953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
